Results
1371
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1371 companies
COSCIENS Biopharma
Market Cap: CA$10.8m
A life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally.
CSCI
CA$3.45
7D
-2.8%
1Y
-35.3%
NUTEX Investments
Market Cap: Ft2.6b
Provides health preserving, health improving, dietary supplement, and cosmetic products in Hungary and internationally.
NUTEX
Ft16.50
7D
0.6%
1Y
-12.9%
Accretion Pharmaceuticals
Market Cap: ₹677.5m
Engages in the manufacturing and marketing of pharmaceutical products in India.
ACCPL
₹60.95
7D
-3.0%
1Y
n/a
NuCana
Market Cap: US$7.6m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer.
NCNA
US$3.98
7D
-0.3%
1Y
-99.3%
Cardio Diagnostics Holdings
Market Cap: US$7.5m
Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
CDIO
US$4.06
7D
4.9%
1Y
-45.9%
Alzamend Neuro
Market Cap: US$7.5m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$2.36
7D
-5.2%
1Y
-84.7%
Aton
Market Cap: €6.4m
Operates as a bioscience company in France.
ALTAO
€0.0078
7D
5.4%
1Y
-37.1%
Godavari Drugs
Market Cap: ₹636.6m
Manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India.
530317
₹84.54
7D
-1.0%
1Y
-33.9%
Percheron Therapeutics
Market Cap: AU$10.9m
Engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia.
PER
AU$0.01
7D
-9.1%
1Y
-90.0%
AcouSort
Market Cap: SEK 67.5m
A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
ACOU
SEK 3.19
7D
-1.5%
1Y
-78.2%
Christina Lake Cannabis
Market Cap: CA$9.9m
A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.
CLC
CA$0.04
7D
-11.1%
1Y
14.3%
Sunshine Biopharma
Market Cap: US$7.1m
Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
SBFM
US$1.52
7D
3.4%
1Y
-50.5%
Phong Phu Pharmaceutical
Market Cap: ₫177.8b
Engages in the production, sale, and distribution of medicines primarily in Vietnam.
PPP
₫20,200.00
7D
-0.5%
1Y
21.7%
Avant Brands
Market Cap: CA$9.4m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.83
7D
2.5%
1Y
-24.5%
Vasundhara Rasayans
Market Cap: ₹597.5m
Engages in the manufacture and sale of antacids therapeutic category of active pharmaceutical ingredients (API) in India and internationally.
538634
₹188.00
7D
-1.8%
1Y
-37.6%
Lasa Supergenerics
Market Cap: ₹596.2m
Engages in the research, manufacture, and marketing of animal and human healthcare products in India.
LASA
₹11.87
7D
-11.7%
1Y
-57.4%
Sonoma Pharmaceuticals
Market Cap: US$6.7m
Develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
SNOA
US$4.06
7D
-4.7%
1Y
26.5%
Ensysce Biosciences
Market Cap: US$6.6m
A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
ENSC
US$2.26
7D
7.6%
1Y
-44.8%
China Pharma Holdings
Market Cap: US$6.5m
Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.
CPHI
US$1.95
7D
-0.8%
1Y
-20.1%
Chimeric Therapeutics
Market Cap: AU$9.8m
A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.
CHM
AU$0.003
7D
-25.0%
1Y
-78.6%
Crescita Therapeutics
Market Cap: CA$9.0m
A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.
CTX
CA$0.47
7D
5.6%
1Y
-20.8%
Jeevan Scientific Technology
Market Cap: ₹554.2m
Engages in the clinical research and data management businesses in India.
538837
₹35.00
7D
-10.5%
1Y
-35.7%
Sprint Bioscience
Market Cap: SEK 59.1m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.56
7D
-1.8%
1Y
-58.0%
Invion
Market Cap: AU$9.4m
A clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.
IVX
AU$0.11
7D
-4.3%
1Y
-45.0%
Theracryf
Market Cap: UK£4.6m
A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.
TCF
UK£0.0022
7D
-12.2%
1Y
-71.3%
Inhalation Sciences Sweden
Market Cap: SEK 65.8m
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.
ISAB
SEK 4.34
7D
0%
1Y
24.4%
Genetic Analysis
Market Cap: NOK 60.8m
A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.
GEAN
NOK 0.88
7D
-15.4%
1Y
31.3%
cbdMD
Market Cap: US$6.0m
Produces and distributes various cannabidiol (CBD) products in the United States.
YCBD
US$0.60
7D
-16.3%
1Y
-84.0%
Murae Organisor
Market Cap: ₹520.5m
Engages in the trade in agriculture activities in India.
542724
₹0.56
7D
-20.0%
1Y
0.2%
Aptevo Therapeutics
Market Cap: US$5.9m
A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.
APVO
US$1.60
7D
-19.2%
1Y
-98.8%
Shelter Pharma
Market Cap: ₹518.2m
Manufactures and sells pharmaceutical products for human and animals in India.
543963
₹44.79
7D
4.2%
1Y
-5.4%
SPM
Market Cap: ₫152.8b
Manufactures and sells pharmaceutical products in Vietnam.
SPM
₫11,100.00
7D
-1.8%
1Y
-2.6%
Rakovina Therapeutics
Market Cap: CA$8.0m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.39
7D
-6.1%
1Y
-59.5%
Biotika
Market Cap: €4.9m
Operates as a pharmaceutical manufacturing company in Slovakia and internationally.
1BSL01AE
€7.00
7D
0%
1Y
-56.3%
Strategic Partners
Market Cap: DKK 36.8m
Does not have significant operations.
STRAP
DKK 882.00
7D
-7.9%
1Y
-23.3%
Titan Pharmaceuticals
Market Cap: US$5.7m
Does not have significant operations.
TTNP
US$4.03
7D
-3.6%
1Y
-23.4%